EcoDrugPlus

Sterol O-Acyltransferase 1

Ensembl ID : ENSOMYG00000020927
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1b

Ensembl ID : ENSOMYG00000077394
Gene Symbol: TACR1B
1 Cross references
188 Possible Orthologues:

Tachykinin Receptor 1b

Ensembl ID : ENSOMYG00000002696
Gene Symbol: TACR1B
1 Cross references
187 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSOMYG00000040878
Gene Symbol: TACR2
1 Cross references
190 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSOMYG00000076557
Gene Symbol: TACR2
2 Cross references
190 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSOMYG00000009204
Gene Symbol: TACR3L
1 Cross references
242 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSOMYG00000010698
Gene Symbol: TACR3L
1 Cross references
242 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSOMYG00000034782
Gene Symbol: TERT
1 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSOMYG00000016166
Gene Symbol: TBXAS1
1 Cross references
213 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSOMYG00000002386
Gene Symbol: TBXAS1
1 Cross references
213 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSOMYG00000004818
Gene Symbol: TBXA2R
1 Cross references
186 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSOMYG00000007570
Gene Symbol: TBXA2R
1 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).